Literature DB >> 4788454

Concomitant immunity to syngeneic methylcholanthrene-induced tumours in mice. Occurrence and specificity of concomitant immunity.

R Kearney, D S Nelson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4788454     DOI: 10.1038/icb.1973.70

Source DB:  PubMed          Journal:  Aust J Exp Biol Med Sci        ISSN: 0004-945X


× No keyword cloud information.
  18 in total

Review 1.  Macrophages: progress and problems.

Authors:  D S Nelson
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

2.  Role of a non-committed accessory cell in the in vivo suppression of a syngeneic tumour by immune lymphocytes.

Authors:  R J Simes; R Kearney; D S Nelson
Journal:  Immunology       Date:  1975-08       Impact factor: 7.397

3.  Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infection.

Authors:  R J North; D P Kirstein; R L Tuttle
Journal:  J Exp Med       Date:  1976-03-01       Impact factor: 14.307

4.  Inhibition of cytokine production by a tumor cell product.

Authors:  E Farram; M Nelson; D S Nelson; D K Moon
Journal:  Immunology       Date:  1982-07       Impact factor: 7.397

5.  II. Tumor growth at sites of inflammation induced by mitogens in mice.

Authors:  M Nelson; D S Nelson
Journal:  Am J Pathol       Date:  1981-08       Impact factor: 4.307

6.  Macrophages and resistance to tumours. I. Inhibition of delayed-type hypersensitivity reactions by tumour cells and by soluble prducts affecting macrophages.

Authors:  M Nelson; D S Nelson
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

Review 7.  Immunology of metastasis. Can the immune response cope with disseminated tumor?

Authors:  P Frost; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

8.  I. Tumor growth in mice with depressed capacity to mount inflammatory responses: possible role of macrophages.

Authors:  M Nelson; D S Nelson; K E Hopper
Journal:  Am J Pathol       Date:  1981-08       Impact factor: 4.307

9.  Inhibition of interleukin-2 production by tumor cell products and by CKS-17, a synthetic retroviral envelope peptide.

Authors:  M Nelson; D Nelson
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

10.  Lymphokine-like products of cultured tumour cells.

Authors:  Y Inoue; C L Geczy; D S Nelson; M Nelson
Journal:  Immunology       Date:  1983-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.